MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ced/llae374

Медицинская библиотека · Clinical and experimental dermatology · 2025

Monoclonal antibodies for the management of cutaneous lupus erythematosus: an update on the current treatment landscape.

Jafari Alexander J, McGee Christina, Klimas Natasha, Hebert Adelaide A

СтатьяОбзорПеревод в очереди

Аннотация

Cutaneous lupus erythematosus (CLE) is a complex autoimmune disease often characterized by a multitude of skin findings. CLE is generally classified into three main categories: acute CLE, subacute CLE and chronic CLE. The current therapeutic guidelines for CLE include counselling patients on general measures and medication regimens. Treatment options include optimized photoprotection, avoidance of environmental triggers, corticosteroids, topical and systemic immunomodulators, and antimalarials. To date, no biologic medications (i.e. monoclonal antibodies, mAbs) are approved for CLE. The first mAb for the treatment of both systemic lupus erythematosus (SLE) and active lupus nephritis was belimumab, and was approved for these diseases in 2011 and 2020, respectively. Belimumab is a specific inhibitor of B-lymphocyte stimulator. Anifrolumab, a type I interferon receptor antagonist, was approved in 2021 for SLE. Other mAbs with different targets, including a novel biologic that inhibits blood dendritic cell antigen 2, are currently under investigation for CLE. This review will describe the general treatment landscape for CLE. Selected studies related to these various mAbs will be discussed, as well as their safety profiles and efficacies demonstrated in clinical trials. Biologic medications can potentially augment the number of treatment options for patients living with CLE.

Для цитирования: Jafari Alexander J, McGee Christina, Klimas Natasha, Hebert Adelaide A. Monoclonal antibodies for the management of cutaneous lupus erythematosus: an update on the current treatment landscape.. Clinical and experimental dermatology. 2025. DOI: 10.1093/ced/llae374.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.